Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simeprevir and Sofosbuvir for HIV/HCV Co-infection
NCT02206932Phase 4Withdrawn
- Sponsor
- University of California, San Francisco
- Start
- Aug 2014
- Primary completion
- Sep 2015
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of simeprevir in hepatitis C virus infection, sponsored by University of California, San Francisco. Planned start Aug 2014; status: withdrawn.
02
Drugs
simeprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02206932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206932.